Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The ATR inhibitor AZD6738 synergizes with gemcitabine in vitro and in vivo to induce pancreatic ductal adenocarcinoma regression.

Wallez Y, Dunlop CR, Johnson TI, Koh SB, Fornari C, Yates JW, Bernaldo de Quirós Fernández S, Lau A, Richards FM, Jodrell DI.

Mol Cancer Ther. 2018 Jun 11. pii: molcanther.0010.2018. doi: 10.1158/1535-7163.MCT-18-0010. [Epub ahead of print]

PMID:
29891488
2.

Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine.

Koh SB, Wallez Y, Dunlop CR, Bernaldo de Quirós Fernández S, Bapiro TE, Richards FM, Jodrell DI.

Cancer Res. 2018 Jun 1;78(11):3054-3066. doi: 10.1158/0008-5472.CAN-17-3932. Epub 2018 May 7.

PMID:
29735549
3.

Developing a quality assurance plan in a medical center.

Hunter SA, Dunlop CR.

QRB Qual Rev Bull. 1980 Sep;6(9):11-5. No abstract available.

PMID:
6777732

Supplemental Content

Loading ...
Support Center